Stock VRNA VERONA PHARMA PLC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Verona Pharma plc

Equities

VRNA

US9250501064

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
15.56 USD +0.58% Intraday chart for Verona Pharma plc -1.02% -21.73%
04-22 European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading MT
04-16 European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Verona Pharma : AGM 2024 Results
PU
Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update
AQ
Verona Pharma : Notice and Proxy Statement AGM 2024
PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)
PU
Verona Pharma : Notice and Proxy Statement AGM 2024
PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)
PU
Andrew Fisher Joins Verona Pharma as General Counsel
AQ
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
AQ
Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
AQ
Michael Austwick Joins Verona Pharma as Non-Executive Director
AQ
Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference
AQ
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital
AQ
Verona Pharma : Change in Certifying Accountants - Form 8-K
PU
Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award
AQ
Verona Pharma Announces November 2023 Investor Conference Participation
AQ
Verona Pharma : VRNA Investor Presentation November 2023
PU
Verona Pharma : VRNA Presentation November 2023
PU
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
AQ
Verona Pharma to Report Third Quarter 2023 Financial Results and Provide Corporate Update
AQ
Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VRNA Stock
  4. News Verona Pharma plc
  5. Press Releases